Triple Negative Breast Cancer

被引：38
作者：
Cetin, Idil [1 ]
Topcul, Mehmet [2 ]
机构：
[1] Istanbul Univ, Fac Sci, Dept Radiobiol, Istanbul, Turkey
[2] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey
来源：
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 2014年 / 15卷 / 06期
关键词：
Triple negative breast cancer; poor prognosis; targeted therapy; ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR; MOLECULAR SUBTYPES; RISK-FACTORS; STEM-CELLS; PROGNOSTIC VALUE; BASAL; CHEMOTHERAPY; CARCINOMA; SURVIVAL;
D O I：
10.7314/APJCP.2014.15.6.2427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Triple-negative breast cancers (TNBC), characterized by absence of the estrogen receptor (ER) and progesterone receptor (PR) and lack of overexpression of human epidermal growth factor receptor 2 (HER2), have a poor prognosis. To overcome therapy limitations of TNBC, various new approaches are needed. This mini-review focuses on discovery of new targets and drugs which might offer new hope for TNBC patients.
引用
收藏
页码：2427 / 2431
页数：5
相关论文
共 70 条
[1]  
[Anonymous], CANC RES S24
[2]   A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair [J].
Ashworth, Alan .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3785-3790
[3]  
Bapat S., 2009, Cancer stem cells, P1
[4]   ZD1839 ('Iressa')1,2 as an anticancer agent [J].
Baselga, J ;
Averbuch, SD .
DRUGS, 2000, 60 (Suppl 1) :33-40
[5]  
Baselga J., 2000, Signal, V1, P12
[6]   Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study [J].
Beiki, Omid ;
Hall, Per ;
Ekbom, Anders ;
Moradi, Tahereh .
BREAST CANCER RESEARCH, 2012, 14 (01)
[7]   Triple-negative breast cancer in the older population [J].
Boyle, P. .
ANNALS OF ONCOLOGY, 2012, 23 :7-12
[8]  
Brady-West DC, 2011, ASIAN PAC J CANCER P, V12, P2139
[9]   Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer Promising Clinical Target or Only a Marker? [J].
Burness, Monika L. ;
Grushko, Tatyana A. ;
Olopade, Olufunmilayo I. .
CANCER JOURNAL, 2010, 16 (01) :23-32
[10]   Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients [J].
Byrski, T. ;
Huzarski, T. ;
Dent, R. ;
Gronwald, J. ;
Zuziak, D. ;
Cybulski, C. ;
Kladny, J. ;
Gorski, B. ;
Lubinski, J. ;
Narod, S. A. .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (02) :359-363
1234567